Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000123743 | SCV000167086 | benign | not specified | 2014-04-23 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Illumina Laboratory Services, |
RCV000343406 | SCV000367048 | uncertain significance | Ataxia-telangiectasia syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000580674 | SCV000682143 | likely benign | Hereditary cancer-predisposing syndrome | 2015-04-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000343406 | SCV002341010 | likely benign | Ataxia-telangiectasia syndrome | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004589617 | SCV005083924 | benign | Familial cancer of breast | 2024-05-15 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is intronic and is not expected to impact mRNA splicing. This variant is strongly associated with less severe personal and family histories of cancer, typical for individuals without pathogenic variants in this gene [PMID: 25085752]. |
Genome Diagnostics Laboratory, |
RCV001795221 | SCV002033945 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001795221 | SCV002036778 | uncertain significance | not provided | no assertion criteria provided | clinical testing |